Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prophylactic thyroid surgery].

A Frilling1, F Weber

  • 1Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsklinikum Essen. frilling@uni-essen.de

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|December 6, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 32 (2021) 439-451].

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Radioembolization with <sup>90</sup>Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy.

Cardiovascular and interventional radiology·2019
Same author

Radioembolization with <sup>90</sup>Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity.

Cardiovascular and interventional radiology·2019
Same journal

[S3 Guideline "Adult soft tissue sarcomas"].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Synopsis-S3 guidelines pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Laparoscopic sentinel node navigation surgery in gastric cancer to reduce surgical radicality].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[ASCO guidelines for the treatment of stage III NSCLC part 4: indications for adjuvant therapy].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Surgical treatment of pancreatic cancer-What is new?]

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
See all related articles

Early diagnosis of thyroid cancer through genetic screening, particularly for RET proto-oncogene mutations, enables timely prophylactic surgery. This approach is crucial for hereditary medullary and potentially nonmedullary thyroid cancers.

Area of Science:

  • Oncology
  • Genetics
  • Surgical Prevention

Background:

  • Early diagnosis of thyroid carcinoma is key for preventive surgical intervention.
  • The RET proto-oncogene is identified as the cause of hereditary medullary thyroid carcinoma.
  • Genotype-phenotype correlations guide current risk-adapted prophylactic surgical strategies.

Purpose of the Study:

  • To highlight the importance of early diagnosis and genetic screening for thyroid cancer.
  • To underscore the role of the RET proto-oncogene in hereditary thyroid cancers.
  • To advocate for risk-adapted prophylactic surgical approaches based on genetic findings.

Main Methods:

  • Identification and characterization of the RET proto-oncogene.
  • Establishing genotype-phenotype correlations for RET mutations.

Related Experiment Videos

  • Review of current prophylactic surgical strategies for hereditary thyroid cancer.

    • Main Results:

    • RET mutations are definitively linked to hereditary medullary thyroid carcinoma.
    • Specific RET mutation types dictate the timing of prophylactic thyroidectomy (e.g., within 1 year for aggressive types, 5-20 years for less virulent types).
    • Emerging research suggests prophylactic surgery may also benefit hereditary nonmedullary thyroid cancer.

    Conclusions:

    • Genetic screening for RET mutations allows for precise, risk-stratified prophylactic surgery in hereditary medullary thyroid carcinoma.
    • Prophylactic thyroidectomy is a curative intervention when performed before neoplastic transformation.
    • Further research into hereditary nonmedullary thyroid cancer genetics is needed to refine management strategies.